Codesmo Desmopressin 0.2mg (Desmopressin Acetate)

Adult dose

Treatment of nocturia associated with nocturnal polyuria (adults only) Administer desmopressin acetate 0.1mg orally at bedtime. If the effect is insufficient after one week, increase the dose to 0.2mg. If the effect remains insufficient, the dose may be increased at one-week intervals up to 0.4mg. Discontinue treatment if there is no clinical effect within 4 weeks after dose adjustment.

Child dose

Primary nocturnal enuresis (5 years and older) Administer 0.2mg of desmopressin acetate orally at bedtime. If the effect is insufficient, the dose may be increased up to 0.4mg. Whether to continue treatment should be determined after 3 months of administration, following a treatment-free period of at least 1 week.

This medication can cause hyponatremia and water intoxication, so particularly elderly patients or those with certain medical conditions should limit fluid intake to the degree needed to satisfy thirst. Patients with a history of allergic reactions to this medication, heart failure, those taking diuretics, and patients with impaired kidney function should not use this medication. Individuals with high blood pressure, chronic kidney disease, women of childbearing potential, children, and the elderly should take special care when using this medication, and those with fluid and electrolyte imbalances must have their conditions thoroughly evaluated before treatment. During the use of this medication, symptoms such as headache, nausea, weight gain, and seizures may occur, so any abnormal symptoms should be reported to a healthcare professional immediately. Fluid intake should be restricted from one hour before administration until at least 8 hours after administration, and in cases of poor kidney function, it should be restricted even more strictly. This medication can interact with other drugs, so caution is needed when taking tricyclic antidepressants, diuretics, non-steroidal anti-inflammatory drugs, etc. Pregnant or breastfeeding women should make careful decisions considering the effects on the fetus or newborn, and if breastfeeding, it is advisable to discontinue breastfeeding. In case of overdose, symptoms of hyponatremia and fluid retention, such as headache, seizures, and loss of consciousness, may occur, so a healthcare professional should be notified immediately, and treatment such as administering diuretics may be necessary.

• coma
• convulsions
• weight gain
• hyponatremia
• emotional disorders
• headache
• abdominal pain
• nausea
• allergic skin reactions
• dizziness

This medication may be sensitive to air or moisture, so it should be stored in a sealed container. The storage temperature should be maintained between 1 to 30 degrees Celsius at room temperature. This will help maintain the medication's efficacy for a longer duration.

Appearance

White or pale yellow powder

Package unit

Company packaging unit